Autopsy report · NCT00562341

Effect of Lap-Band Induced Weight Loss on Serum PSA Levels

“enrollment challenges”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Maimonides Medical Center

Sponsor type

University, hospital or other

Conditions

Obesity; Prostate Cancer

Interventions

Bariatric Surgery

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification
  “Major challenge for enrollment of participants.” (88% match in meaning)
• (SGB) in Men Treated for Prostate Cancer Improve Hot Flashes
  “Enrollment issues” (86% match in meaning)
• Study of Neoadjuvant Imprime PGG and Pembrolizumab for Stage III, Resectable Melanoma
  “Enrollment challenges, study not feasible” (85% match in meaning)
• Multicentric Study Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts
  “Difficulties of enrollment” (85% match in meaning)
• Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT)
  “difficult enrollment” (85% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.